A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with Candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3. (Q36110315)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with Candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3. |
scientific article |
Statements
1 reference
A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with Candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3. (English)
1 reference
William W Greenfield
1 reference
Shawna L Stratton
1 reference
Rebecca S Myrick
1 reference
Rita Vaughn
1 reference
Lisa M Donnalley
1 reference
Hannah N Coleman
1 reference
Maria Mercado
1 reference
Andrea M Moerman-Herzog
1 reference
Horace J Spencer
1 reference
Nancy R Andrews-Collins
1 reference
Wilbur C Hitt
1 reference
Gordon M Low
1 reference
Nirvana A Manning
1 reference
Samantha S McKelvey
1 reference
Dora Smith
1 reference
Michael V Smith
1 reference
Amy M Phillips
1 reference
C Matthew Quick
1 reference
Susanne K Jeffus
1 reference
Laura F Hutchins
1 reference
Mayumi Nakagawa
1 reference
27 May 2015
1 reference
1 reference
e1031439
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference